Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a biotechnology company focused on developing innovative therapies that enhance the effectiveness of radiation therapy for cancer treatment. The company operates in the life sciences sector, specializing in the research and development of sensitizers, which are designed to improve the efficacy of radiation therapy. By leveraging cutting-edge technology and scientific research, Shuttle Pharmaceuticals aims to offer solutions that enhance cancer treatment outcomes.